Skip to main content

Michael Kauffman, M.D., Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Kyntra Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get KYNB alerts

About Michael Kauffman, M.D., Ph.D.

Michael Kauffman, M.D., Ph.D. is recorded as Board Member at Kyntra Bio, Inc. (KYNB) since June 4, 2025. Kyntra Bio, Inc. reported in an 8-K filed June 9, 2025 that Michael Kauffman, M.D., Ph.D. was appointed Class III director, effective June 4, 2025. Kyntra Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyntra Bio, Inc. includes James A. Schoeneck (CEO), Thane Wettig (CEO and Board Member), Thomas B. Neff (CEO) and 3 others.

“Effective June 4, 2025, the Board of the Company, upon recommendation of the Nominating and Corporate Governance Committee, appointed Michael Kauffman, M.D., Ph.D. as a Class III director of the Company.”
Kyntra Bio, Inc. Form 8-K, filed June 9, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2025-06-04–present

Leadership on record at Kyntra Bio, Inc.

Recent activity